Dear BCN-Affiliated Medical Care Group Business Administrator:
We’d like to invite you, your primary care physicians, pharmacists and support staff to an upcoming webinar discussing our new end-to-end precision medicine pharmacogenomics (PGx) program called Blue Cross Personalized Medicine℠. This program uses PGx to personalize medication treatments based on FDA recognized gene-drug interactions. BCN has contracted with OneOme®, an independent precision medicine company co-founded by Mayo Clinic, to provide this program for eligible BCN and BCN Advantage℠ members with a pharmacy benefit. The program is scheduled to launch in January 2023.
CME credit is available to providers who may register for this free, one-hour session to be held on Thursday, Nov. 10, from 2 to 3 p.m.
The webinar will focus on the primary care physician’s vital role in helping achieve better patient outcomes through medication optimization. It will also describe the patient experience from invitation through testing completion and demonstrate how medication treatment options can be tailored to individual needs. In addition, the webinar will include specific case study success stories for multiple disease states and specialties.
You can read more about Blue Cross Personalized Medicine and our upcoming educational opportunities in the Nov-Dec. 2022 issue of BCN Provider News, page 7.
Please forward this opportunity along to your primary care physicians, pharmacists and support staff and encourage them to attend.